BISCAYNE NEUROTHERAPEUTICS
Biscayne Neurotherapeutics is a clinical-stage biotechnology company developing novel therapies for difficult-to-treat neurological disorders. Biscayne’s lead compound, BIS-001, is in clinical development for the treatment of refractory forms of epilepsy. Biscayne Neurotherapeutics has an experienced executive team with an extensive track record of successful drug development, and its scientific advisors include a number of highly respected experts studying seizure and other CNS disorders. The company is headquartered in Miami, Florida, and benefits from the growing entrepreneurial South Florida biomedical sector.
BISCAYNE NEUROTHERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.biscayneneuro.com
Total Employee:
1+
Status:
Active
Contact:
212 584-2276
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Founder
Investors List
Quark Venture
Quark Venture investment in Series B - Biscayne NeuroTherapeutics
Mesa Verde Venture Partners
Mesa Verde Venture Partners investment in Series B - Biscayne NeuroTherapeutics
Official Site Inspections
http://www.biscayneneuro.com
- Host name: ec2-3-19-116-195.us-east-2.compute.amazonaws.com
- IP address: 3.19.116.195
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
